In the near future, the cell culture media industry is poised to undergo a significant transformation, driven by advancements in biotechnology, personalized medicine, and increased demand for cell-based therapies. With growing emphasis on precision medicine and regenerative therapies, there will be a surge in the development of innovative cell culture media formulations tailored to specific cell types and applications. These cutting-edge media will be optimized to support the growth and functionality of various cells, including stem cells, primary cells, and specialized cell lines. Moreover, the integration of artificial intelligence and machine learning into media development processes will enable rapid optimization and customization, resulting in highly efficient and cost-effective solutions. As the industry continues to evolve, collaborations between academia, research institutions, and biotechnology companies will play a pivotal role in accelerating advancements and ultimately revolutionizing the landscape of cell culture media, paving the way for groundbreaking discoveries and transformative medical treatments.
Cell Culture Media Market in terms of revenue was estimated to be worth $6.2 Billion in 2023 and is poised to reach $13.0 Billion by 2028, growing at a CAGR of 16.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of the market is majorly attributable to increased demand for biosimilars and mAbs globally, rising investment & funding for stem cell research, focus of key market players on launch of novel products in the market.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97468536
Browse in-depth TOC on "Cell Culture Media Market"
314 - Tables
41 - Figures
291 – Pages
In 2022, the serum-free media segment accounted for the largest share of the type segment in the cell culture media market.
On the basis of type, the cell culture media market is divided into serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, and other cell culture media. In 2022, the serum-free media segment holds for the bigest share of the market. Factors responsible for the growth of this segment includes various advantages or benefits of serum-free media over other types of cell culture media.
In 2022, the biopharmaceutical production segment accounted for the largest share of the application segment in the cell culture media market.
On the basis of application, the cell culture media market is categorized into biopharmaceutical production, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is estimated to grow at the highest growth rate during the forecast period. Factors responsible for the growth include, the growing production of cell culture-based vaccines, and expansion of pharmaceutical industry. The biopharmaceutical production applications of cell culture media include the manufacturing of biologic-based products such as vaccines, monoclonal antibodies, and other therapeutic proteins (such as anticoagulants, enzymes, blood factors, hormones, interferons, growth factors, interleukins, engineered proteins, and thrombolytics, among others).
In 2022, the Asia Pacific region is the fastest-growing region of the cell culture media market.
On the basis of the region, the global cell culture media market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. During the forecast period, the Asia Pacific market is estimated to register the highest CAGR during the forecast period. Increased focus of key market players on geographical expansion in emerging markets, favorable government policies and support for cell-based vaccines in the region and less manufacturing cost are some of the major factors anticipated to have positive impact on the market growth of Asia Pacific region.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=97468536
Cell Culture Media Market Dynamics:
DRIVER: Increasing demand for serum and animal component-free media
Fetal bovine serum (FBS) is the most widely used and preferred media supplement for cells culture. FBS contains several growth factors and hormones that can help for cell growth, but there are several disadvantages of using FBS such as batch-to-batch variability in serum composition, limited availability, impact on performance and safety of a cell product, potential pathogen transmission and animal welfare considerations. This has driven the shift towards the development and adoption of serum-free cell culture processes.
RESTRAINT: Expensive cell biology research products
Cell biology involves extensive research on the development of new therapies, such as stem cell and gene therapies. The media, reagents, and other products associated with this research are required to be of high quality in order to obtain accurate results. Owing to the need to maintain high-quality standards and comply with guidelines set up by regulatory authorities, the cost of research in cell biology is high.
OPPORTUNITY: Increasing incidence of infectious diseases and outbreaks of pandemics
Cell culture has a wide range of applications in providing diagnostic/prognostic information as well as during research related to HIV/AIDS, cancer, and various infectious diseases. Several factors, such as the growth in the population, climate change, and increasing contact between humans and animals, have increased the threat of new virus outbreaks. Cancer, which has become the leading cause of death globally, accounted for 9.96 million deaths in 2020. According to GLOBOCAN, the number of cancer cases will rise to approximately 30 million by 2040. The growth in the prevalence of this disease has resulted in a need to conduct extensive research for diagnosis and treatment. This in turn offers growth opportunities for cell culture technologies and cell culture media products.
CHALLENGE: Survival of small players and new entrants
The survival of small players and new entrants in the cell culture media industry is a significant challenge. Established players such as Thermo Fisher Scientific, Inc. (US), Lonza Group AG (Switzerland), Sartorius AG (Germany), Merck KGaA (Germany), and Danaher Corporation (US) account for a major share of the market. These players have a strong brand recognition and robust product portfolio. It is difficult for small players and new entrants to compete in this market, considering the strong presence of major players. Also, as established players that have large R&D budgets it is difficult for small players to sustain their operations and compete with established players as large investments are required for the R&D and launch of innovative products.
Key Market Players:
Key players in the cell culture media market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), Miltenyi Biotec (Germany), and among others.
Recent Developments:
- In June 2023, Thermo fisher launched Tumoroid Culture Medium to accelerate development of novel cancer therapies.
- In April 2023, FUJIFILM Irvine Scientific launched BalanCD CHO Media Platform Portfolio for Bioprocessing.
- In March 2022, FUJIFILM Irvine Scientific acquired Shenandoah Biotechnology. The deal would help the company to provide customers with a single point of access for their life science research, discovery, and cell and gene therapy needs.
- In January 2022, Cytiva and Nucleus Biologics LLC collaborated to enhance custom cell media development for cell and gene therapies.
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=97468536
Cell Culture Media Market Advantages:
- Versatility: Cell culture media provide a versatile platform for the growth and maintenance of various types of cells, including primary cells, stem cells, and cell lines derived from different tissues and species. This versatility allows researchers to study and manipulate diverse cell populations, facilitating a wide range of applications in basic research, drug discovery, and regenerative medicine.
- Reproducibility: High-quality cell culture media formulations are standardized and extensively tested, ensuring consistent and reproducible results across different experiments and laboratories. This reliability is essential for generating meaningful and reliable data, which is critical for the advancement of scientific knowledge.
- Customizability: The cell culture media market offers customizable formulations to cater to specific cell types and experimental requirements. Researchers can optimize media components to suit the unique needs of their cells, enhancing cell growth, proliferation, and differentiation, ultimately leading to more accurate and reliable experimental outcomes.
- Scalability: Cell culture media have been developed to support large-scale production of cells, making them integral to biopharmaceutical manufacturing. With the increasing demand for cell-based therapies and biologics, scalable media solutions play a vital role in ensuring the efficient and cost-effective production of therapeutic cells and products.
- Safety and Purity: High-quality cell culture media are manufactured under stringent quality control standards to ensure the absence of contaminants that may compromise cell viability or introduce experimental artifacts. These safety measures are essential to maintain the integrity of research findings and the safety of biopharmaceutical products.
- Reduced Dependency on Animal Models: Advanced cell culture media formulations have contributed to reducing reliance on animal models in research, as they allow scientists to conduct more relevant experiments using human or cell-based models. This ethical advantage aligns with the growing focus on reducing animal testing while still advancing scientific progress.
- Technological Advancements: The cell culture media market continually evolves, incorporating technological advancements, such as serum-free or xeno-free formulations, to improve cell culture systems' efficiency and reproducibility. These innovations empower researchers to work with more physiologically relevant and defined conditions, yielding results that better translate to clinical applications.
- Accelerated Drug Discovery: Robust cell culture media accelerate drug discovery processes by enabling high-throughput screening of potential drug candidates on various cell models. This expedites the identification of promising compounds, shortens development timelines, and reduces drug development costs.
- Overall, the cell culture media market's advantages have revolutionized modern biomedical research, playing a pivotal role in advancing scientific knowledge, drug development, and regenerative medicine, while contributing to the growth of the biotechnology and pharmaceutical industries.
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-culture-media-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-culture-media.asp
